Efficacy and tolerability of anticholinergics in Korean children with overactive bladder: a multicenter retrospective study.

Abstract

We investigated the efficacy and tolerability of various anticholinergics in

Korean children with non-neurogenic overactive bladder (OAB). A total of 326

children (males:females= 157:169) aged under 18 yr (mean age 7.3+/-2.6 yr) who

were diagnosed with OAB from 2008 to 2011 were retrospectively reviewed. The mean

duration of OAB symptoms before anticholinergic treatment was 16.9+/-19.0 months.

The mean duration of medication was 5.6+/-7.3 months. Urgency urinary

incontinence episodes per week decreased from 1.9+/-3.1 to 0.4+/-1.5 times

(P<0.001). The median voiding frequency during daytime was decreased from

9.2+/-5.4 to 6.3+/-4.2 times (P<0.001). According to 3-day voiding diaries, the

maximum and average bladder capacity were increased from 145.5+/-66.9 to

196.8+/-80.3 mL and from 80.8+/-39.6 to 121.8+/-56.5 mL, respectively (P<0.001).

On uroflowmetry, maximum flow rate was increased from 17.6+/-8.4 to 20.5+/-8.2

mL/sec (P<0.001). Adverse effects were reported in 14 (4.3%) children and six

children (1.8%) discontinued medication due to adverse effects. Our results

indicate that anticholinergics are effective to improve OAB symptoms and

tolerability was acceptable without severe complications in children.